MA-TA-ASSOCIATES
TA Associates, a leading global growth private equity firm, today announced that it has completed a majority investment in Masquepet S.L. (“Kiwoko”). Corpfin Capital Fund III (“Corpfin Capital”) and Prince Capital Partners, S.C.R., S.A. (“Prince Capital”) have exited their investment in Kiwoko, selling their 89.4% stake to TA Associates and the founders of Kiwoko. Financial terms of the transaction were not disclosed.
Founded in 2007 by Álvaro Gutiérrez, Javier Osa and Emilio Goyanes, and headquartered in Madrid, Kiwoko is the largest chain of pet care specialty retail stores in Spain. Over the last nine years, and with the financial support of Corpfin Capital and Prince Capital, the founders have grown Kiwoko to become Iberia’s sector leader with approximately 90 stores in Spain and Portugal.
Prince Capital and the founders provided Kiwoko with seed capital to start the business and, in February 2012, invited Corpfin Capital to provide the growth capital required to continue to grow the company. Since then, Kiwoko has successfully implemented an ambitious expansion plan that has resulted in the opening of 43 new stores and 40 vet clinics, the acquisition and integration of several smaller chains, including Mr. Guau and Zona Mascota, and the development of a full online business. During this period, Kiwoko generated approximately 700 new jobs and achieved more than 3,000 animal adoptions.
With TA Associates’ support, Kiwoko will seek to capitalize on significant growth opportunities in the Iberian pet care market.
“Kiwoko’s impressive expansion and notable business momentum is a perfect fit for TA’s growth-focused consumer investment strategy,” said Patrick Sader, a Director at TA Associates who will join Kiwoko’s Board of Directors. “We are delighted to partner with Álvaro and Javi to support Kiwoko in its next stage of organic and acquisitive growth.” Christopher Parkin, a Managing Director at TA Associates, will also join Kiwoko’s Board of Directors.
"It has been a privilege for Corpfin Capital to have the opportunity to partner with Prince Capital to support such an extraordinary team of entrepreneurs as Kiwoko’s founders,” said Álvaro Olivares, the Partner at Corpfin Capital responsible for Kiwoko. “TA Associates’ involvement will help Kiwoko rapidly develop to its full potential.”
"We are pleased to have supported Kiwoko through its start-up stage and to have partnered with Corpfin Capital to develop the company into an industry leader led by a talented, engaged management team,” said Jesús Torres, CEO of Prince Capital. “Kiwoko is exemplary of the opportunity for growth and investment in the Spanish retail sector, and we believe TA Associates’ guidance will further the company’s ability to compete with the large European market players.”
"We are very grateful to Corpfin and Prince for their trust and support during the last eight years, and are confident that TA’s support will allow us to expand Kiwoko’s leadership position, helping Spanish and Portuguese pet owners improve the lives of their pets,” said Javier Osa and Álvaro Gutiérrez, co-founders of Kiwoko.
Latham & Watkins served as legal counsel to TA Associates. Alemany, Escalona & De Fuentes served as legal advisor to Corpfin Capital and Prince Capital.
About TA Associates
TA Associates is one of the largest and
most experienced global growth private equity firms. The firm has
invested in more than 460 companies around the world and has raised $24
billion in capital. With offices in Boston, Menlo Park, London, Mumbai
and Hong Kong, TA Associates leads buyouts and minority
recapitalizations of profitable growth companies in the business
services, consumer, financial services, healthcare and technology
industries. More information about TA Associates can be found at www.ta.com
.
About Corpfin Capital
Corpfin Capital is the longest
established independent private equity firm in the Spanish market with
more than 25 years of experience. Since its founding, Corpfin Capital
has successfully managed c. €700 million with an investment strategy
focused on the local and international expansion of Spanish SMEs across
a wide variety of sectors. Corpfin Capital is currently investing
Corpfin Capital Fund IV, from which it has already completed various
acquisitions such as: Logiters (number two contract logistics company in
Spain), El Fornet (fast growing regional coffee and bakery chain),
Preving Group (build-up in employee health and safety compliance
services), Secna (global producer of natural colorants for the food
industry), and Arenal (fast growing hygiene, beauty and health specialty
retailer).
About Prince Capital Partners
Prince Capital Partners is the
first and only private venture capital company in Asturias. It was
established in February 2008 with the vocation of making the necessary
financial resources available to Spanish companies so that they can make
the most of their potential for growth and expansion, prioritizing
companies that are undergoing a process of business consolidation.
Currently, Prince Capital is a shareholder in Azvase (a company offering
services for the elderly), Coonic (the communication agencies and
marketing online group), and Huni Hotel School (educational project
focused on tourism). Prince is managed by Torsa Capital, SGEIC SA, an
entity that has begun the fundraising of a new private equity fund and
expects to have it operational by the end of the year.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160629006506/en/
Contact:
TA Associates
Marcia O’Carroll, 617-574-6796
mocarroll@ta.com
or
BackBay
Communications
Stephen Fishleigh, +44-203-475-7552
stephen.fishleigh@backbaycommunications.com
or
Philip
Nunes, 617-391-0792
phil.nunes@backbaycommunications.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release
~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut
The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release
The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the
Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release
Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom